This article is more than 5 years old. Information may no longer be current.
Top stories in gastroenterology: highlights from Digestive Disease Week, including exclusive videos on obesity treatment, checkpoint inhibitor cancer therapy
Click Here to Manage Email Alerts
All the top stories in gastroenterology this week come from the recently completed Digestive Disease Week meeting. According to one study, focal cryoballoon ablation was effective in treatment of esophageal squamous cell neoplasia, while other research showed that clenpig was effective and safe for patients who underwent colonoscopy.
Other top stories from the meeting include a machine learning model that successfully identified all polyps in colonoscopies, an exclusive video perspective that reviewed obesity-focused data, and another video which shared some insightful research about checkpoint inhibitor-induced diarrhea. – by Jake Scott
Cryoballoon ablation effectively treats esophageal squamous cell neoplasia
Focal cryoballoon ablation was effective for the treatment of esophageal squamous cell neoplasia, a precursor to squamous cell cancer, according to early results from a study that was presented. Read more.
Ready-to-drink solution superior to powder for colonoscopy bowel prep
Clenpiq showed efficacy and safety for patients who undergo colonoscopy, according to research that was presented. Additionally, study data revealed the ready-to-drink solution was superior to a powder solution. Read more.
Computer-assisted polyp detection similar to expert colonoscopists
A machine learning model successfully identified all polyps in colonoscopies previously reviewed by expert colonoscopists and even found a few more, according to research that was presented. Read more.
Obesity treatment integral to gastroenterology care
In this exclusive video perspective, Sarah Streett, MD, from the Stanford University Medical Center and outgoing chair of the American Gastroenterological Association Practice Management and Economics Committee, reviews obesity-focused data presented at the meeting and obesity’s importance in gastroenterology and hepatology. Read more.
Severe diarrhea an important side effect of checkpoint inhibitor cancer therapy
In this exclusive video, Joseph Murray, MD, of the Mayo Clinic in Rochester, Minn., shares some insight on research about checkpoint inhibitor-induced diarrhea. Read more.